Pilot Research

试点研究

• 批准号: 8753291
• 负责人: Israel DAVID GOLDMAN
• 金额: $ 28.99万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-23 至 2018-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8753291
• 关键词: Address; Advisory Committees; Albert Einstein Cancer Center; Applications Grants; Award; Cancer Center; Cancer Center Support Grant; Clinical; Clinical Research; Collaborations; Data; Disease; Focus Groups; Funding; Goals; Grant; Integration Host Factors; Laboratories; Neoplasm Metastasis; Pilot Projects; Research; Research Personnel; Resource Sharing; Strategic Planning; Translational Research; malignant breast neoplasm; meetings; programs; tumor; tumor microenvironment; working group

Several pilot project RFAs were offered over this funding period to specifically address AECC goals identified within the context of the Center's strategic planning mechanism and the yearly meetings of the External Scientific Advisory Committee, (i) The first pilot project RFA issued in 2008 was focused on stimulating collaborations between clinical and laboratory investigators with the objective of promoting translational research within the context of a clinical study. A requirement was that the investigator participated in a disease-oriented focus group at the AECC Advances retreat, (ii) The second pilot project RFA was issued in Spring 2010. This initiative grew out of the Breast Cancer Working Group's activities and need to strengthen translational research in breast cancer with the context of the Tumor Microenvironment and Metastasis program. The RFA requested a range of proposals that address tumor and/or host factors contributing to metastasis, predictive markers of metastases, etc. (iii) The third RFA (January 2011) provided grants to support utilization of AECC Shared Resources in order to obtain preliminary data to support a grant application. Total awards in support of all pilot projects through the CCSG mechanism was $350,000. Representative projects supported by the CCSG are described here.

在此资助期间提供了几个试点项目 RFA，专门解决在中心战略规划机制和外部科学咨询委员会年度会议范围内确定的 AECC 目标， (i) 2008 年发布的第一个试点项目 RFA 重点关注促进临床和实验室研究人员之间的合作，以促进临床研究背景下的转化研究。一项要求是研究者参加了 AECC Advances 务虚会上的以疾病为导向的焦点小组，(ii) 第二个试点项目 RFA 于 2010 年春季发布。该举措源于乳腺癌工作组的活动，需要加强转化在肿瘤微环境和转移计划的背景下进行乳腺癌研究。 RFA 要求提出一系列提案，以解决导致转移的肿瘤和/或宿主因素、转移的预测标记物等。 (iii) 第三次 RFA（2011 年 1 月）提供拨款支持 AECC 共享资源的利用，以获得初步结果支持拨款申请的数据。通过 CCSG 机制支持所有试点项目的奖金总额为 350,000 美元。此处描述了 CCSG 支持的代表性项目。